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Abstract
The GPIIb-IIIa complex functions as a receptor for cytoadhe-
sive proteins on the platelet surface. Both GPIIb and GPIIIa
are synthesized by a human erythroleukemia (HEL) cell line.
We isolated several cDNA clones by screening a HEL cell
cDNA library with an oligonucleotide derived from amino acid
sequence of GPIIb. Nucleotide and amino acid sequences were
determined from 703 bp of one of these clones. Amino acid
sequence of purified platelet GPIIb peptides confirmed the
identity of the clone. The cDNA encodes the carboxyl terminus
of the large (a) subunit of GPIIb and all of the smaller (f6)
subunit of GPIIb. By hybridizing the cDNA directly to chro-
mosomes separated by dual laser chromosome sorting, the
gene for GPIIb was mapped to chromosome 17. Northern blot
analysis showed a - 3.4-kb GPIIb mRNA in HEL cells. We
also compared the amino acid sequences determined from eight
additional platelet GPIIb peptides with the derived amino
acids from a published HEL cell GPIIb cDNA, and the plate-
let and HEL cell proteins appear to be the same. Despite
previous reports that vascular endothelial cells and monocytes
contain GPIIb, no GPIIb mRNA was observed in either type of
cell. Thus, GPIIb appears to be specific for the platelet-mega-
karyocyte membrane and is distinct from the a subunits of the
adhesion receptors in other normal tissues.
Introduction
A critical step in maintaining normal hemostasis is the aggre-
gation of platelets during the formation of blood clots. Failure
of platelets to aggregate results in bleeding, as is seen in the
hereditary disorder, Glanzmann's thrombasthenia (1). The
platelets of these patients are deficient in membrane GPIIb
and GPIIIa (2). GPIIb and GPIIIa mediate platelet aggregation
by acting as the receptor for fibrinogen, an adhesion molecule
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that binds platelets to one another in the blood clot (3). As
determined by SDS-PAGE, unreduced GPIIb has an apparent
Mr of 142,000 (4). Electrophoresis of the reduced protein re-
veals two disulfide-linked subunits; GPIIba (Mr of 123,000)
and GPIIb, (Mr of 22,000) (4) that are synthesized as a single-
chain precursor (5). GPIIIa is a single-chain glycoprotein.
GPIIb and GPIIIa are associated as a noncovalent, calcium-
dependent heterodimer in the platelet membrane (for review,
see reference 1).
Recent evidence suggests that the GPIIb-IIIa complex be-
longs to a class of receptors that bind cell adhesion molecules
(for review, see reference 6). These receptors share a common
heterodimeric structure with a and ,B subunits. Platelet GPIIb
and GPIIIa correspond to the a and ,3 subunit, respectively
(not to be confused with GPIIba and GPIIbO,, the subunits of
reduced mature platelet GPIIb). GPIIb-IIIa is able to bind not
only fibrinogen (3), but other cytoadhesive proteins, such as
fibronectin (7), vitronectin (8), and von Willebrand factor (9).
In contrast, Pytela et al. observed that when extracted from
human placenta, the receptor for fibronectin binds only fibro-
nectin, and that the vitronectin receptor binds only to vitro-
nectin (8). All of these adhesion molecules contain the cell
attachment sequence Arg-Gly-Asp (10), but the factors that
confer ligand specificity (i.e., fibrinogen binds to GPIIb-IIIa
but not to the fibronectin receptor [8]) are unknown.
Study ofthe genes encoding platelet proteins is particularly
difficult for two reasons: (i) platelets are anucleate and synthe-
size little or no protein (11), and (ii) megakaryocytes, the pre-
cursor cells of platelets, comprise only 0.1% of all cells in the
bone marrow and are therefore difficult to purify quantita-
tively. The human erythroleukemia (HEL)' cell line possesses
some features of megakaryocytes (12, 13). Specific polyclonal
antibodies raised against reduced or nonreduced GPIIb or
GPIIIa have been shown to react with HEL cell proteins of
comparable molecular weight on Western blots (5, 12). At least
seven different monoclonal antibodies against platelet GPIIb,
GPIIIa, or the GPIIb-IIIa complex react with intact HEL cells
(I 2-15). Therefore, HEL cells represent a good model for anal-
ysis of the genes for GPIIb and GPIIIa.
We have constructed a cDNA library in the XgtlO vector
using HEL cell RNA, and have cloned and sequenced a partial
cDNA for GPIIb. Poncz et al. have recently published the
cDNA for the entire coding region ofGPIIb, also derived from
HEL cell RNA (16). We report here that the gene for GPIIb is
located on chromosome 17. Also, Northern blot analysis re-
1. Abbreviations used in this paper: HEL, human erythroleukemia;
HUVE, human umbilical vein endothelial.
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veals the absence of GPIIb mRNA in human umbilical vein
endothelial (HUVE) cells and peripheral blood monocytes,
cells in which GPIIb-like proteins have been previously re-
ported. We also provide additional platelet amino acid se-
quence confirming the equivalence of HEL cell and platelet
GPIIb.
Methods
GPIIb amino acid sequence determination. GPIIb was isolated as de-
scribed (5). Methods of amino acid determination will be described in
detail in another manuscript (manuscript in preparation). Briefly, pu-
rified reduced-alkylated GPIIb was digested with trypsin and sepa-
rated by reverse-phase HPLC. Amino acid sequencing from the NH2
terminus of intact IIb, and the resultant peptides was performed using
a gas phase protein sequencer (model 470 A; Applied Biosystems, Inc.,
Foster, City, CA). Several attempts to sequence the NH2 terminus of
IIB6, proved unsuccessful. Therefore, Ilbs was cleaved by cyanogen
bromide and subjected to sequencing.
Oligonucleotide synthesis. Using the amino acid sequence of
GPIIb,6, a 48-bp oligonucleotide was designed according to Lathe (17)
and synthesized by the phosphotriester method (Oligonucleotide
Chemistry Systems Laboratories, Denton, TX).
Tissues. Human peripheral blood monocytes were isolated from a
normal donor platelet pheresis residue bag, as described (18). After
separation, Wright's stain and esterase stain showed 96% monocytes,
4% lymphocytes, and no visible platelets. HUVE cells were isolated
from freshly prepared human umbilical cords by collagenase digestion
and cultured with serial passages as described ( 19).
RNA preparation. Total RNA was extracted from various cell lines
and tissues by the guanidinium thioisocyanate method (20). Poly(A)+
RNA was selected by elution from an oligo(dT)-cellulose column (21).
For construction of the cDNA library, HEL cell poly(A)+ RNA was
fractionated on a 15-30% sucrose gradient, and then subjected to a
second purification over an oligo(dT)-cellulose column. The various
poly(A)+ RNA fractions were translated in vitro and the resulting
proteins immunoprecipitated and electrophoresed to determine the
fraction most enriched for GPIlb mRNA. Fractions corresponding to
poly(A)+ RNAs of 3 kb and larger were pooled.
cDNA library construction. 4 ,g of size-selected poly(A)+ RNA was
used to synthesize the oligo(dT)-primed first strand of cDNA (22).
Second strand was made using RNase H and DNA polymerase I (23).
The cDNA was made blunt-ended, treated with Eco RI methylase,
ligated to Eco RI linkers (Pharmacia Fine Chemicals, Piscataway, NJ)
and digested with Eco RI (22). This cDNA was fractionated on a 1%
agarose gel to size-select for cDNAs > 0.9 kb and to remove free
linkers. cDNAs were eluted from gel slices, and then ligated into the
XgtlO vector and packaged (both XgtlO vector and packaging extract
from Stratagene Cloning Systems, San Diego, CA).
Screening of the XgtJO HEL cell library. The GPIIba, 48-mer was
end-labeled with y[32P]ATP, and 2 X 106 cpm probe per milliliter
hybridization solution was used to screen 700,000 recombinants. Hy-
bridization conditions were: 5X standard saline citrate (SSC) ( 1X SSC
is 150 mM NaCl, 15 mM sodium citrate)/5x Denhardt's solution
(Denhardt's is 0.02% Ficoll, 0.02% polyvinylpyrrolidone, 0.02%
BSA)/ I0% formamide at 370C for 12 h. Filters were washed in 2x SSC
at 22°C, then in 0.3x SSC/0.1% SDS at 51°C. Phage DNA was pre-
pared and digested with Eco RI. The sizes of the cDNA inserts ranged
from 720 to 2,000 bp. The Eco RI insert from one of the positive
clones, XH3.1, was ligated into the pBS plasmid vector (Stratagene
Cloning Systems).
Nucleotide sequencing. The Eco RI insert of XH3. 1 was ligated into
M13mpl9 and the nucleotide sequence was determined using the di-
deoxynucleotide chain termination method (24).
Chromosomal localization of the GPIIb gene. The chromosomal
localization of the GPIIb gene was analyzed by hybridization of the
cDNA directly to the DNA of chromosomes resolved by dual laser
chromosome sorting (25).
cDNA probes. Northern blots were probed with the 32P-labeled 0.7
kb Eco RI insert of XH3. 1 and with a 2.2-kb Eco RI fragment from the
5' end of the cDNA for GPIIIa (manuscript in preparation). This latter
cDNA was obtained from the HEL cell cDNA library described above
and is 99% homologous to that obtained by Fitzgerald et al. from a
HUVE cell cDNA library (26). Additional probes used as positive
controls were a 404-bp Eco RI fragment of the 5' end of the von
Willebrand factor cDNA (19) and the 3' 1.8 kb Eco RI fragment of the
fi subunit of the leukocyte adhesion proteins (27).
Northern blot analysis. Poly(A)+ RNA was electrophoresed on a 1%
agarose 2.2 M formaldehyde gel and blotted to nitrocellulose or nylon
filters. Nitrocellulose filter hybridization was performed with 2 X 106
cpm/ml probe in 50% formamide/ I X Denhardt's solution/3X SSC/50
mM NaPO4 (pH 7.0)/200 gg/ml salmon sperm DNA/10% dextran
sulfate at 420C for 12 h. Filters were washed in 0.1 X SSC/0. 1% SDS at
55°C. Nylon filters were hybridized with 2 X 106 cpm/ml probe in 7%
SDS/0.5 M NaPO4 (pH 7.2)/10% dextran sulfate at 65°C and washed
in 2X SSC/1% SDS at 65°C.
Results
A cDNA library containing 2.6 x 106 recombinants was con-
structed from HEL cell poly(A)+ RNA. 700,000 recombinants
were screened at high plating density and 28 clones were iden-
tified that reacted with a GPIIb, synthetic oligonucleotide.
Only twelve were pursued on secondary screening, and seven
of these clones were positive on secondary and tertiary screen-
ing. To confirm the authenticity of one clone, XH3. 1, its nu-
cleotide sequence was determined (Fig. 1). When translated,
the open reading frame corresponds to 172 amino acids. The
derived sequence was compared with 11 residues of a GPIIb#
peptide (Table I, peptide 6) obtained by tryptic digestion; all 11
matched (Fig. 1, amino acids 11 1-121). We also compared the
derived sequence with 19 residues of a GPIIb, peptide ob-
tained by cleavage with cyanogen bromide (Table I, peptide
i3CNBr); 17 amino acids matched (Fig. 1, amino acids
154-170) and the first and last residues were ambiguous. In
both discrepant residues, a minor HPLC signal was identical to
the nucleotide-derived amino acid. Hiraiwa et al. (28) se-
quenced two GPIIb peptides, one of which matched 12 of our
derived amino acids, 161-172 (Fig. 1). Because their sequence
overlapped all but one of our GPIIb,6 peptide residues, it was
not indicated in Fig. 1. Moreover, all 15 residues of the GPIIb,
NH2 terminus published by Charo et al. (29) were identical
with a segment of our predicted sequence (Fig. 1, amino acids
36-50). We conclude that the XH3. 1 cDNA includes the entire
sequence for GPIIbo. The cDNA also codes for 35 amino acids
that precede the NH2 terminus ofGPIIb, and presumably rep-
resents the COOH-terminal end of GPIIba.
We compared both our cDNA nucleotide sequence and
platelet GPIIb peptide sequences with the data of Poncz et al.
(16). All 703 nucleotides ofour XH3. 1 clone matched perfectly
with the 3' end of their cDNA (comparison not shown). Table I
lists the 10 platelet GPIIb peptides that we sequenced. Peptides
6 and "pCNBr" are contained in GPIIb,6 and shown in Fig. 1.
Ofthe remaining 8 peptides, 153 residues were assigned. When
compared with the published amino acid sequence derived
from the HEL cell GPIIb cDNA (16), 151 matched (compari-
son not shown).
The chromosomal location ofthe GPIIb gene was analyzed
by hybridization of the 32P-labeled XH3. 1 Eco RI restriction
fragment directly to the DNA of chromosomes resolved by
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1 Val Asp Trp Gly Leu Pro Ile Pro Ser Pro Ser Pro
1 AG GTG GAC TGG GGG CTG CCC ATC CCC AGC CCC TCC CCC
13 Ile His Pro Ala His His Lys Arg Asp Arg Arg Gln Ile
39 ATT CAC CCG GCC CAT CAC AAG CGG GAT CGC AGA CAG ATC
26 Phe Leu Pro Glu Pro Glu Gln Pro Ser Arg 4Leu Gln Asp
78 TTC CTG CCA GAG CCC GAG CAG CCC TCG AGG CTT CAG GAT
39 Pro Val Leu Val Ser Cys Asp Ser Ala Pro Cys Thr Val
117 CCA GTT CTC GTA AGC TGC GAC TCG GCG CCC TGT ACT GTG
52 Val Gln Cys Asp Leu Gln Glu Met Ala Arg Gly Gln Arg
156 GTG CAG TGT GAC CTG CAG GAG ATG GCG CGC GGG CAG CGG
65 Ala Met Val Thr Val Leu Ala Phe Leu Trp Leu Pro Ser
195 GCC ATG GTC ACG GTG CTG GCC TTC CTG TGG CTG CCC AGC
78 Leu Tyr Gln Arg Pro Leu Asp Gln Phe Val Leu Gln Ser
234 CTC TAC CAG AGG CCT CTG GAT CAG TTT GTG CTG CAG TCG
91 His Ala Trp Phe Asn Val Ser Ser Leu Pro Tyr Ala Val
273 CAC GCA TGG TTC AAC GTG TCC TCC CTC CCC TAT GCG GTG
104 Pro Pro Leu Ser Leu Pro Arg Gly Glu Ala Gln Val Trp
312 CCC CCG CTC AGC CTG CCC CGA GGG GAA GCT CAG GTG TGG
117 Thr Gln Leu Leu Arq Ala Leu Glu Glu Arg ATa Ile Pro
351 ACA CAG CTG CTC CGG GCC TTG GAG GAG AGG kCC: ST CC
130 Ile Trp Trp Val Leu Val Gly Val Leu Gly Gly Leu Leu
390 AC TGG TGG GTG CTG GTG GGT GTG CTG GGT GGC CTG CT
143 Leu Leu Thr Ile Leu Val Leu Ala Met Trp Lys Val Gly
429 ICTG CTC ACC ATC CTG GTC CTG GCC ATG T GG AAG GTC GGC
156 Phe Phe Lys Arg Asn Arg Pro Pro Leu Glu Glu Asp Asp
468 TTC TTC AAG CGG AAC CGG CCA CCC CTG GAA GAA GAT GAT
169 Glu Giu Gly Glu Stop
507 GAA GAG GGG GAG TGA TGGTGCAGCCTACACTATTCTAGCAGGAGGGTTG
556 GGCGTGCTACCTGCACCGCCCCTTCTCCAACAAGTTGCCTCCAAGCTTTGGGTTGG
612 AGCTGTTCCATTGGGTCCTCTTGGTGTCGTTTCCCTCCCAACAGAGCTGGGCTACC
668 CCCCCTCCTGCTGCCTAATAAA&GAGACTGAGCCCTGAAAAAAAAAAAA(n)
dual laser chromosome sorting (Fig. 2). The gene for GPIIb
mapped uniquely to chromosome 17. Not shown are chromo-
somes 9-12. In a second experiment, the XH3. 1 clone did not
hybridize to chromosomes 9-12, but did bind to chromo-
some 17.
To study tissue expression, we used the XH3. 1 cDNA and a
GPIIIa cDNA fragment to probe for mRNA expression in
HEL cells, HUVE cells, and normal human circulating mono-
cytes. HEL cells contain a single - 3.4-kb species of GPIIb
mRNA (Fig. 3, lane 1) and a - 6-kb species of GPIIIa RNA
(Fig. 3, lane 2). The faint signal at - 3-kb (Fig. 3, lane 2) has
been a consistent observation and may represent a spliced
GPIIIa message. GPIIb message was not detected in mRNA
from either HUVE cells or monocytes (Fig. 3, lanes 3 and 6,
respectively). When endothelial mRNA was probed with
GPIIb cDNA under less stringent conditions (same as in
Methods, except hybridization performed at 37°C and wash-
ing performed in 2X SSC/0.1% SDS), no GPIIb message was
detected (data not shown). However, when probed with GPIIIa
cDNA, a single - 6-kb message was observed in mRNA from
HUVE cells, but none in the monocytes (Fig. 3, lanes 4 and 7,
Figure 1. Derived amino acid
and nucleotide sequence of par-
tial HEL cell GPIIb cDNA. The
XH3. 1 clone was subcloned into
Ml 3mp19 and complete se-
quence was obtained in both ori-
entations. Numbering begins at
the 5' end of the XH3. 1 clone.
Identical platelet peptide se-
quences are indicated by double-
underlined regions. Underline
breaks indicate ambiguities in
peptide sequencing. The boxed
region is the putative hydropho-
bic transmembrane segment
( 16). The single underline at nu-
cleotide 684 represents the poly-
adenylation signal. The potential
N-linked glycosylation site (*)
and the IIba-Ibp cleavage site G)
are indicated.
respectively). As positive controls, a cDNA probe for von Wil-
lebrand factor (Fig. 3, lane 5) and for the ,B subunit of the
leukocyte adhesion proteins (Fig. 3, lane 8) identified the ap-
propriate 8.5 kb (30) and 3.0 kb (27) mRNAs, respec-
tively, in endothelial cells and monocytes. Note that when the
filter used in Fig. 3, lane 3 was probed with the GPIIIa cDNA,
the 6-kb mRNA was seen (data not shown), and that Fig. 3,
lanes 6, 7, and 8 represent the same filter hybridized in three
separate experiments. Northern blot analysis indicated - 20-
fold less GPIIb mRNA in K562 cells than in HEL cells, and
absence of GPIIb mRNA in reticulocytes (data not shown).
Discussion
We have obtained a partial cDNA clone coding for the
COOH-terminal portion of GPIIb. There was perfect identity
between the derived amino acids of this cDNA and 43 amino
acids from platelet GPIIb6. The 703 nucleotides of our cDNA
clone are identical to the 3' end of the cDNA published by
Poncz et al. (16). Additionally, we found 151 of 153 amino
acids from 8 platelet GPIIb peptides matched the recently
1814 Bray et al.
Table I. Amino Acid Sequencefrom Platelet GPIIb Peptides
Peptide Sequence
D
aNH2terminus LNLDPVQLTFYAGP(X)GSQFGFSLTFHK(X)SHG(R)VA(I)V(V)G
NVGSQTLQTFK
IYV(E)NDFSWDKR
VYLFLQPR
F(X)S AI APLG D LD(X) DGYN(X) IA VA APYGG PSG R
(A) LG PS Q E E TGG V FL (X) PW R
GEAQVWTQLLR
GPHALGAPSLLLTGTQLYGR
p
(X) R PS Q V L DS PFDTG S A FG FS L R
(S) K VG F F K R N R PP L E E D (D) (E) (Y)
Amino acid sequences of the NH2 termini of GPIIb., tryptic peptides of GPIIb, and the cyanogen bromide peptide (JSCNBR) of GPIIbB.
Amino acid residues are given in the single-letter code. Tryptic peptides were identified by assigning a number to the peak on the chromato-
graphic profile. Tentatively assigned residues are in parentheses; undetermined residues are indicated by "X". The published cDNA-derived
amino acids ( 16) at variance with our residues are indicated above our peptides and in bold lettering.
published sequence ofHEL cell GPI~b (16). When considered
in light of immunologic and biochemical evidence (5, 12-15),
the data strongly suggest that platelet and HEL cell GPIIb are
the same protein.
Northern blot analysis of HEL cell poly(A)+ RNA reveals
that the message for GPIIb is 3.4 kb. This is somewhat
smaller than the 4.1-kb reported by Poncz et al. (16). The
discrepancy is likely due to the different denaturing gel systems
used and/or the different molecular weight markers employed.
Once the 5' untranslated region has been cloned, the true
mRNA size can be determined.
Several reports have indicated that human endothelial cells
synthesize a complex related to GPIIb-II1a (31-34). When
cultured HUVE cells were surface radiolabeled, solubilized,
and immunoprecipitated with anti-GPIIIa antisera, an a-(3 he-
terodimeric complex was observed (31-34). Based on immu-
nologic evidence (35) and comparisons of partial peptide se-
quence from GPIIIa with the sequence from an endothelial
cell cDNA (26), it appears that platelet GPIIIa and the endo-
thelial j3 subunit are identical. However, direct immunological
evidence that the a subunit ofHUVE cells is platelet GPIIb has
never been obtained. Moreover, our present work shows ab-
2 1 3.4 2 r.x.8 5 4 3 3
sence of GPIIb mRNA from HUVE cells. Also, we have been
unable to detect an immunologically related GPIIb molecule
in HUVE cells by Western blotting using a polyclonal anti-
GPIIb antibody (unpublished observation). These data indi-
cate that once the HUVE cell adhesion receptor complex is
dissociated by SDS-PAGE, the a subunit is not recognized by
anti-GPIIb antisera. Our findings are in disagreement with an
HEL HUVE Monocyte
28S -
18S-
1 2 3 4 5 6 7 8
17 18 13' 20
Figure 2. Autoradiogram of dot-blot filters of sorted (
32P-radiolabeled cDNA (0.72 kb restriction fragment
to the DNA of chromosomes resolved by dual laser c
sorting and bound to nitrocellulose. Numbers refer t(
some(s) isolated.
Figure 3. Identification of GPIIb and GPIIIa mRNA by Northern
blot analysis Poly(A)' RNA from HEL cells (10 Mg, lanes I and 2),
HUVE cells (3 Mg, lane 3; 2 Mg, lane 4; 3 jg, lane 5), and normal
human circulating monocytes (1 Mg, lanes 6, 7, and 8) was electro-
12 21 22 phoresed and transferred to nitrocellulose. These filters were probed
with 32P-labeled cDNA for GPIIb (lanes 1, 3, and 6), GPIIIa (lanes 2,
4, and 7), von Willebrand factor (lane 5), and the # subunit of the
chromosomes. leukocyte adhesion proteins (lane 8). Lanes I and 2 exposed at 22°C
) was hybridized without intensifying screens for 12 h. Lanes 3-8 exposed at -70°C
hromosome with intensifying screens for 12 h (lanes 3-5 and 8) or 4 d (lanes 6
o chromo- and 7). 28S and 18S ribosomal markers are indicated by the upper
and lower arrows, respectively, in each panel.
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2
3
4
5
6
7
8
#CNBr
14.15 16.7 16
earlier report in which antisera apparently specific for GPIIba
immunoprecipitates the HUVE cell a-3 heterodimeric com-
plex (29). An explanation for this disagreement would be that
the anti-GPIIba antisera has minor reactivity with GPIIIa.
Thus, in contrast to GPIIIa, our results indicate that the a
subunit of the HUVE cell heterodimer is distinct from platelet
GPIIb. The term "GPIIb" should not be used to describe the a
subunit ofHUVE cells.
The identity of the a subunit of the endothelial cell adhe-
sion receptor is not known. When we probed endothelial
mRNA with the XH3. 1 cDNA under nonstringent conditions,
no homologous mRNA was identified. The adhesion receptor
on endothelial cells may be analogous to the vitronectin re-
ceptor, in which the ,3 subunit is likely to be identical to plate-
let GPIIIa and the a subunit different from GPIIb (36).
There has been speculation that the f3 subunits of other cell
adhesion receptors share more homologies than the a subunits
(37). Since GPIIb-IIIa binds additional ligands not bound by
other adhesion receptors (7), our findings suggest that GPIIb is
likely to be important in conferring receptor-ligand specificity.
Several comments regarding monocyte expression of
GPIIb can be made based on the results of our Northern blot
analysis. Evidence for (38-40) and against (41, 42) the pres-
ence of GPIIb and GPIIIa in monocytes has been presented.
Our data reveals no GPIIb or GPIIIa mRNA in monocytes.
Because we analyzed only 1 jug of poly(A)+ monocyte RNA,
we cannot rule out very low levels of expression. However,
probing the same filter under identical hybridization condi-
tions, we were able to detect both the Factor XIII a-chain, a
cytoplasmic protein, (18) and the i3 subunit of the leukocyte
adhesion proteins (Fig. 3, lane 8), a membrane cytoadhesion
protein similar to GPIIIa. Therefore, it is unlikely that mono-
cytes contain either GPIIb or GPIIIa.
We have mapped the gene for, GPIIb to chromosome 17.
We are currently conducting experiments to localize the gene
for GPIIIa. These results will have implications with regard to
the genetic mechanism for Glanzmann's thrombasthenia. If
the gene for GPIIta is on chromosome 17, then either a gene
deletion or a defect in a regulatory element controlling tran-
scription of both genes could explain why GPIIb and GPIIIa
are absent or decreased in parallel in the platelets of patients
with this disease.
The ligand binding sites on the GPIIb-IIIa complex and the
structural features required for the subunit assembly have not
been characterized. Cloning of the cDNA for GPIIb and
GPIIIa will allow experiments in which the protein products
can be selectively altered so that answers to these questions can
be obtained.
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